International Biotechnology Trust plc

IBT

GB0004559349

Investment Trusts

Market Closed - London S.E. Other stock markets 11:35:29 2024-06-05 am EDT			5-day change	1st Jan Change
642 ^GBX	+1.26%		+2.88%	0.00%

May. 30	CORRECT (May 08): International Biotechnology half-year NAV rises	AN
May. 08	EARNINGS: International Biotechnology bullish; Andrews Sykes profit up	AN

International Biotechnology Trust plc Reports Earnings Results for the Half Year Ended February 29, 2024

May 08, 2024 at 02:00 am EDT

International Biotechnology Trust plc reported earnings results for the half year ended February 29, 2024. For the half year, the company reported net income was GBP 28.33 million compared to GBP 16.96 million a year ago. Basic earnings per share from continuing operations was GBP 0.7287 compared to GBP 0.4157 a year ago.

Latest news about International Biotechnology Trust plc

CORRECT (May 08): International Biotechnology half-year NAV rises	May. 30	AN
EARNINGS: International Biotechnology bullish; Andrews Sykes profit up	May. 08	AN
Earnings Flash (IBT.L) INTL. BIOTECHNOLOGY TRUST Posts Fiscal H1 Revenue GBP650,000	May. 08	MT
Earnings Flash (IBT.L) INTL. BIOTECHNOLOGY TRUST Posts Fiscal H1 EPS GBX72.87	May. 08	MT
International Biotechnology Trust plc Reports Earnings Results for the Half Year Ended February 29, 2024	May. 08	CI
Tranche Update on International Biotechnology Trust Plc's Equity Buyback Plan announced on December 13, 2023.	May. 08	CI
Tranche Update on International Biotechnology Trust Plc's Equity Buyback Plan announced on March 2, 2023.	May. 08	CI
Transcript : International Biotechnology Trust plc - Special Call	Mar. 12
International Biotechnology Trust plc commences an Equity Buyback Plan for 5,851,887 shares, representing 15.05% of its issued share capital, under the authorization approved on December 12, 2023.	Dec. 13	CI
International Biotechnology Trust plc Elects Gillian Elcock as Director	Dec. 12	CI
International Biotechnology Trust plc Declares Payment of A First Interim Dividend for the Year Ending 31 August 2023, Payable on 26 January 2024	Dec. 12	CI
International Biotechnology Trust plc Approves Dividend Policy	Dec. 12	CI
International Biotechnology Trust plc's Equity Buyback announced on March 2, 2023, has expired. with 1,881,222 shares.	Dec. 12	CI
Origin Enterprises kicks off EUR20 million buyback	Nov. 20	AN
EARNINGS: Wynnstay "optimistic" despite climate, dotdigital ups profit	Nov. 07	AN
Earnings Flash (IBT.L) INTL. BIOTECHNOLOGY TRUST Posts FY23 Revenue GBP863,000	Nov. 07	MT
International Biotechnology Trust plc Reports Earnings Results for the Full Year Ended August 31, 2023	Nov. 07	CI
Tranche Update on International Biotechnology Trust Plc's Equity Buyback Plan announced on March 2, 2023.	Nov. 07	CI
International Biotechnology Trust Selects Schroders as Fund Manager	23-08-03	MT
International Biotechnology Trust plc Declares the Second Interim Dividend for the Period Ending 31 August 2023, Payable on 25 August 2023	23-07-05	CI
Grafenia "cautiously optimistic" about year ahead	23-05-03	AN
Earnings Flash (IBT.L) INTL. BIOTECHNOLOGY TRUST Reports H1 EPS GBX41.57	23-05-03	MT
International Biotechnology Trust plc Reports Earnings Results for the Half Year Ended February 28, 2023	23-05-03	CI
International Biotechnology Trust plc commences an Equity Buyback Plan for 6,124,285 shares, representing 14.99% of its issued share capital, under the authorization approved on December 6, 2022.	23-03-02	CI
SV Health notifies International Biotechnology of termination in 2024	23-02-13	AN

Chart International Biotechnology Trust plc

Duration

Period

Chart International Biotechnology Trust plc

More charts

Company Profile

International Biotechnology Trust plc is a United Kingdom-based investment trust company. The Companyâs investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company seeks to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialization of a product, device or enabling technology. The Companyâs investments may also be made in related sectors, such as medical devices and healthcare services. The Company may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. SV Health Managers LLP is the Company's alternative investment fund manager (AIFM).

Sector

Investment Trusts

Calendar

2024-10-28 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6.34

Average target price

Consensus

Annual profits - Rate of surprise

Company calendar

Sector Investment Trusts

	1st Jan change	Capi.
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	0.00%	304M
SCOTTISH MORTGAGE INVESTMENT TRUST PLC	+11.44%	15.04B
F&C INVESTMENT TRUST PLC	+3.95%	6.37B
POLAR CAPITAL TECHNOLOGY TRUST PLC	+19.27%	4.65B
ALLIANCE TRUST PLC	+6.83%	4.3B
GREENCOAT UK WIND PLC	-7.66%	4.09B
RIT CAPITAL PARTNERS PLC	-4.14%	3.35B
JPMORGAN GLOBAL GROWTH & INCOME PLC	+6.56%	3.27B
THE MONKS INVESTMENT TRUST PLC	+10.17%	3.15B
SMITHSON INVESTMENT TRUST PLC	-2.05%	2.82B

Investment Trusts